{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:16:22Z","timestamp":1791065782065,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T00:00:00Z","timestamp":1641513600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007436","name":"Familjen Erling-Perssons Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020142","name":"Center for Medical Innovation, Swanson School of Engineering, University of Pittsburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020142","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018713","name":"Center for Innovative Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004348","name":"Stockholms L\u00e4ns Landsting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006310","name":"Medicinska Forskningsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006310","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004063","name":"Knut och Alice Wallenbergs Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004063","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Med"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.medj.2022.01.001","type":"journal-article","created":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T02:46:27Z","timestamp":1642646787000},"page":"137-153.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Salivary IgG to SARS-CoV-2 indicates seroconversion and correlates to serum neutralization in mRNA-vaccinated immunocompromised individuals"],"prefix":"10.1016","volume":"3","author":[{"given":"Katie","family":"Healy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2158-2674","authenticated-orcid":false,"given":"Elisa","family":"Pin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puran","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"S\u00f6derdahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8325-9215","authenticated-orcid":false,"given":"Stephan","family":"Mielke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotta","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3306-3713","authenticated-orcid":false,"given":"Peter","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.I. Edvard","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"Ljungman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Valentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7167-7882","authenticated-orcid":false,"given":"Ola","family":"Blennow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"\u00d6sterborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6936-4919","authenticated-orcid":false,"given":"Giorgio","family":"Gabarrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0787-5849","authenticated-orcid":false,"given":"Khaled","family":"Al-Manei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Alkharaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2932-1994","authenticated-orcid":false,"given":"Micha\u0142 Jacek","family":"Sobkowiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamil","family":"Yousef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Mravinacova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica","family":"Cuapio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinling","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Akber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7679-9494","authenticated-orcid":false,"given":"Karin","family":"Lor\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0880-5375","authenticated-orcid":false,"given":"Cecilia","family":"Hellstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Muschiol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordana","family":"Bogdanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0633-1719","authenticated-orcid":false,"given":"Marcus","family":"Buggert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Gustaf","family":"Ljunggren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0605-8417","authenticated-orcid":false,"given":"Sophia","family":"Hober","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4657-8532","authenticated-orcid":false,"given":"Peter","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0461-4870","authenticated-orcid":false,"given":"Soo","family":"Aleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"S\u00e4llberg Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medj.2022.01.001_bib1","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1056\/NEJMoa2027906","article-title":"Safety and immunogenicity of two RNA-based covid-19 vaccine candidates","volume":"383","author":"Walsh","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.medj.2022.01.001_bib2","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.medj.2022.01.001_bib3","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJMoa2101765","article-title":"BNT162b2 mRNA covid-19 vaccine in a nationwide mass vaccination setting","volume":"384","author":"Dagan","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.medj.2022.01.001_bib4","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(21)00947-8","article-title":"Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data","volume":"397","author":"Haas","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.medj.2022.01.001_bib5","article-title":"Effectiveness of COVID-19 vaccines against the B.1.617.2 variant","author":"Bernal","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.medj.2022.01.001_bib6","article-title":"Age-dependent immune response to the Biontech\/Pfizer BNT162b2 COVID-19 vaccination","author":"M\u00fcller","year":"2021","journal-title":"Clin. Infect Dis."},{"key":"10.1016\/j.medj.2022.01.001_bib7","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41586-021-03412-7","article-title":"Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies","volume":"593","author":"Collier","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.medj.2022.01.001_bib8","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2021.26.12.2100329","article-title":"Robust antibody responses in 70-80-year-olds 3\u00a0weeks after the first or second doses of Pfizer\/BioNTech COVID-19 vaccine, United Kingdom, January to February 2021","volume":"26","author":"Subbarao","year":"2021","journal-title":"Euro Surveill."},{"key":"10.1016\/j.medj.2022.01.001_bib9","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jaci.2020.12.620","article-title":"COVID-19 in patients with primary and secondary immunodeficiency: the United Kingdom experience","volume":"147","author":"Shields","year":"2021","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.medj.2022.01.001_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abl4348","article-title":"X-linked recessive TLR7 deficiency in \u223c1% of men under 60 years old with life-threatening COVID-19","volume":"6","author":"Asano","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.medj.2022.01.001_bib11","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abl4340","article-title":"Autoantibodies neutralizing type I IFNs are present in \u223c4% of uninfected individuals over 70 years old and account for \u223c20% of COVID-19 deaths","volume":"6","author":"Bastard","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.medj.2022.01.001_bib12","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1186\/1710-1492-7-S1-S11","article-title":"Primary immunodeficiency","volume":"7","author":"McCusker","year":"2011","journal-title":"Allergy Asthma Clin. Immunol."},{"key":"10.1016\/j.medj.2022.01.001_bib13","year":"2017","journal-title":"Immunodeficiency"},{"key":"10.1016\/j.medj.2022.01.001_bib14","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/ejh.13223","article-title":"Current clinical practice and challenges in the management of secondary immunodeficiency in hematological malignancies","volume":"102","author":"Na","year":"2019","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.medj.2022.01.001_bib15","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1056\/NEJMc2031670","article-title":"Shedding of viable SARS-CoV-2 after immunosuppressive therapy for cancer","volume":"383","author":"Aydillo","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.medj.2022.01.001_bib16","first-page":"1","article-title":"Prolonged SARS-CoV-2 RNA virus shedding and lymphopenia are hallmarks of COVID-19 in cancer patients with poor prognosis","author":"Goubet","year":"2021","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.medj.2022.01.001_bib17","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.medj.2022.01.001_bib18","article-title":"Impaired humoral immunity to SARS-CoV-2 vaccination in non-hodgkin lymphoma and CLL patients","author":"Diefenbach","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/j.medj.2022.01.001_bib19","doi-asserted-by":"crossref","DOI":"10.1111\/ajt.16726","article-title":"Serological response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients depends on prior exposure to SARS-CoV-2","author":"Firket","year":"2021","journal-title":"Am. J. Transpl."},{"key":"10.1016\/j.medj.2022.01.001_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2021.05.029","article-title":"Immunogenicity of Pfizer-BioNTech COVID-19 vaccine in patients with inborn errors of immunity","author":"Hagin","year":"2021","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"key":"10.1016\/j.medj.2022.01.001_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.26284","article-title":"BNT162b2 COVID-19 vaccine is significantly less effective in patients with hematologic malignancies","author":"Herzog Tzarfati","year":"2021","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.medj.2022.01.001_bib22","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jhep.2021.04.020","article-title":"Low immunogenicity to SARS-CoV-2 vaccination among liver transplant recipients","volume":"75","author":"Rabinowich","year":"2021","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.medj.2022.01.001_bib23","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/s41591-021-01296-8","article-title":"SARS-CoV-2 infection of the oral cavity and saliva","volume":"27","author":"Huang","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.medj.2022.01.001_bib24","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/S0140-6736(20)30607-3","article-title":"First known person-to-person transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the USA","volume":"395","author":"Ghinai","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.medj.2022.01.001_bib25","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0140-6736(20)30528-6","article-title":"Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures","volume":"395","author":"Pung","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.medj.2022.01.001_bib26","doi-asserted-by":"crossref","first-page":"606","DOI":"10.15585\/mmwr.mm6919e6","article-title":"High SARS-CoV-2 attack rate following exposure at a choir practice - Skagit County, Washington, March 2020","volume":"69","author":"Hamner","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep."},{"key":"10.1016\/j.medj.2022.01.001_bib27","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/0022034520957289","article-title":"Oral manifestations in patients with COVID-19: a living systematic review","volume":"100","author":"Amorim Dos Santos","year":"2021","journal-title":"J.\u00a0Dent Res."},{"key":"10.1016\/j.medj.2022.01.001_bib28","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1038\/s41467-021-23473-6","article-title":"Immune response to SARS-CoV-2 variants of concern in vaccinated individuals","volume":"12","author":"Becker","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.medj.2022.01.001_bib46","author":"Marais"},{"key":"10.1016\/j.medj.2022.01.001_bib29","first-page":"103705","article-title":"Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial","volume":"74","author":"Bergman","year":"2021","journal-title":"BioMedicine"},{"key":"10.1016\/j.medj.2022.01.001_bib30","doi-asserted-by":"crossref","first-page":"e1312","DOI":"10.1002\/cti2.1312","article-title":"Systematic evaluation of SARS-CoV-2 antigens enables a highly specific and sensitive multiplex serological COVID-19 assay","volume":"10","author":"Hober","year":"2021","journal-title":"Clin. Transl Immunol."},{"key":"10.1016\/j.medj.2022.01.001_bib31","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/infdis\/jiab256","article-title":"Persisting salivary IgG against SARS-CoV-2 at 9\u00a0months after mild COVID-19: a complementary approach to population surveys","volume":"224","author":"Alkharaan","year":"2021","journal-title":"J.\u00a0Infect Dis."},{"key":"10.1016\/j.medj.2022.01.001_bib32","first-page":"46","article-title":"A cell-free high throughput assay for assessment of SARS-CoV-2 neutralizing antibodies","volume":"66","author":"Mravinacova","year":"2021","journal-title":"N.\u00a0Biotechnol."},{"key":"10.1016\/j.medj.2022.01.001_bib33","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.03149-20","article-title":"Quantitative measurement of anti-SARS-CoV-2 antibodies: analytical and clinical evaluation","volume":"59","author":"Higgins","year":"2021","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.medj.2022.01.001_bib34","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.medj.2022.01.001_bib36","doi-asserted-by":"crossref","first-page":"eabe5511","DOI":"10.1126\/sciimmunol.abe5511","article-title":"Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in patients with COVID-19","volume":"5","author":"Isho","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.medj.2022.01.001_bib37","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.addr.2011.02.008","article-title":"New developments and opportunities in oral mucosal drug delivery for local and systemic disease","volume":"64","author":"Hearnden","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.medj.2022.01.001_bib38","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1172\/JCI6968","article-title":"Bidirectional FcRn-dependent IgG transport in a polarized human intestinal epithelial cell line","volume":"104","author":"Dickinson","year":"1999","journal-title":"J.\u00a0Clin. Invest"},{"key":"10.1016\/j.medj.2022.01.001_bib39","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1385\/IR:29:1-3:055","article-title":"Intestinal epithelial cell regulation of mucosal inflammation","volume":"29","author":"Yu","year":"2004","journal-title":"Immunol. Res."},{"key":"10.1016\/j.medj.2022.01.001_bib40","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1001\/jama.2021.7489","article-title":"Antibody Response to 2-Dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients","volume":"325","author":"Boyarsky","year":"2021","journal-title":"Jama"},{"key":"10.1016\/j.medj.2022.01.001_bib41","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2021.12339","article-title":"Antibody response after a third dose of the mRNA-1273 SARS-CoV-2 vaccine in kidney transplant recipients with minimal serologic response to 2 doses","author":"Benotmane","year":"2021","journal-title":"Jama"},{"key":"10.1016\/j.medj.2022.01.001_bib42","first-page":"1","article-title":"Covid-19 in patients with chronic lymphocytic leukemia: clinical outcome and B- and T-cell immunity during 13\u00a0months in consecutive patients","author":"Blixt","year":"2021","journal-title":"Leukemia"},{"key":"10.1016\/j.medj.2022.01.001_bib43","doi-asserted-by":"crossref","first-page":"eabd2223","DOI":"10.1126\/scitranslmed.abd2223","article-title":"IgA dominates the early neutralizing antibody response to SARS-CoV-2","volume":"13","author":"Sterlin","year":"2021","journal-title":"Sci. Translational Med."},{"key":"10.1016\/j.medj.2022.01.001_bib44","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s41586-021-03653-6","article-title":"BNT162b2 vaccine induces neutralizing antibodies and poly-specific T\u00a0cells in humans","volume":"595","author":"Sahin","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.medj.2022.01.001_bib45","series-title":"R: A Language and Environment for Statistical Computing","author":"Team","year":"2021"}],"container-title":["Med"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634022000368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666634022000368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T02:55:04Z","timestamp":1763002504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666634022000368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S2666634022000368"],"URL":"https:\/\/doi.org\/10.1016\/j.medj.2022.01.001","relation":{},"ISSN":["2666-6340"],"issn-type":[{"value":"2666-6340","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Salivary IgG to SARS-CoV-2 indicates seroconversion and correlates to serum neutralization in mRNA-vaccinated immunocompromised individuals","name":"articletitle","label":"Article Title"},{"value":"Med","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medj.2022.01.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}